HUMAN CLONING AND FDA REGULATION

DSpace/Manakin Repository

. . . . . .

Title:	HUMAN CLONING AND FDA REGULATION
Author:	Vosk, Ted
Citation:	HUMAN CLONING AND FDA REGULATION (1998 Third Year Paper)
Full Text & Related Files:	tvosk.pdf (231.1Kb; PDF) tvosk.rtf (89.10Kb; RTF file) tvosk.html (69.71Kb; HTML)
Abstract:	In the February 27, 1997 issue of the journal Nature scientists from Scotland's Roslin Institute reported their successful efforts to clone an adult sheep using differentiated somatic cells from the animal. The clone, named Dolly, was the first instance of the successful cloning of an adult mammal. The shock waves created by the possible ramifications of this development were immediately felt around the world. For the first time, the cloning of an adult human being was no longer being considered an impossibility in mainstream scientific circles. Scientists, governments and laymen around the world were now forced to began considering the consequences of utilizing this new technology to clone adult human beings.
Terms of Use:	This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page:	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8889437